Intellia Therapeutics (NTLA) Cash & Current Investments (2015 - 2026)
Intellia Therapeutics (NTLA) recorded Cash & Current Investments of $437.76 million in Q2 2026, down 4.8% from $459.65 million a year earlier but up 16.4% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Cash & Current Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Intellia Therapeutics reported Cash & Current Investments of $449.88 million, down 25.2% from FY2024.
- Annual Cash & Current Investments has declined for three straight years, with a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $601.52 million in FY2024 (-34.1%), $912.22 million in FY2023 (-23.5%), $1.19 billion in FY2022 (+58.9%) and $750.77 million in FY2021 (+25.7%).
- Quarterly Cash & Current Investments has ranged from $375.99 million in Q1 2026 to $1.19 billion in Q4 2022 over the past five years.
- On a year-over-year basis, Cash & Current Investments has declined for 11 consecutive quarters, with an average decline of 25.6% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 95.7% in Q3 2021, against a decline of 36.3% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $375.99 million (Q1 2026), $449.88 million (Q4 2025) and $511.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Intellia Therapeutics | 1.49 Bn | -285.04 Mn | - | 437.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 437.76 Mn |
| Mar 31, 2026 | 375.99 Mn |
| Dec 31, 2025 | 449.88 Mn |
| Sep 30, 2025 | 511.04 Mn |
| Jun 30, 2025 | 459.65 Mn |
| Mar 31, 2025 | 503.75 Mn |
| Dec 31, 2024 | 601.52 Mn |
| Sep 30, 2024 | 658.11 Mn |
| Jun 30, 2024 | 691.07 Mn |
| Mar 31, 2024 | 791.29 Mn |
| Dec 31, 2023 | 912.22 Mn |
| Sep 30, 2023 | 854.79 Mn |
| Jun 30, 2023 | 908.07 Mn |
| Mar 31, 2023 | 933.54 Mn |
| Dec 31, 2022 | 1.19 Bn |
| Sep 30, 2022 | 828.19 Mn |
| Jun 30, 2022 | 874.28 Mn |
| Mar 31, 2022 | 855.25 Mn |
| Dec 31, 2021 | 750.77 Mn |
| Sep 30, 2021 | 798.27 Mn |
API Access
Intellia Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();